Peter Rossing - Concepedia

Author

Peter Rossing

Also Known As

Bellazzi, Riccardo, Buse, J.B., David J. Roberts, G. Derumeaux, Giuseppe M C Rosano, Giuseppe M. C. Rosano, Hirschhorn, Joel N, Holst, Ian H. de Boer, J McMurray

1.4K

Publications

76.5K

Citations

120

H-Index

158

Concepts

All Affiliations

Steno Diabetes Centers University of Copenhagen Aarhus University Rigshospitalet University Medical Center Groningen

About

Peter Rossing is an author at Steno Diabetes Centers specializing in medicine, diabetes, and chronic kidney disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	67	155	16.8K
2	Public Health	26	34	5.5K
3	Health Sciences	14	17	716
4	Natural Sciences	2	2	298
5	Engineering	1	1	10

Peter Rossing

500

Publications

53K

Citations

108

H-Index

Page 1

	Year	Citations
Dapagliflozin in Patients with Chronic Kidney Disease Hiddo J.L. Heerspink, Bergur V. Stefánsson, Ricardo Correa‐Rotter, New England Journal of Medicine	2020	4.8K
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Melanie J. Davies, David A. D’Alessio, Judith Fradkin, Diabetes Care	2018	3.4K
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes George L. Bakris, Rajiv Agarwal, Stefan D. Anker, New England Journal of Medicine	2020	2.4K
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Melanie J. Davies, David A. D’Alessio, Judith Fradkin, Diabetologia American Diabetes AssociationMetabolic SyndromeDiabetes ManagementDiabetes EpidemiologyHealth Policy	2018	1.4K
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Vlado Perkovic, Katherine R. Tuttle, Peter Rossing, New England Journal of Medicine	2024	1.2K
2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) John B. Buse, Deborah J. Wexler, Peter Rossing, Diabetes Care Heart FailureAmerican Diabetes AssociationMetabolic SyndromeDiabetes EpidemiologyConsensus Report	2019	1.1K
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis Rajiv Agarwal, Gerasimos Filippatos, Bertram Pitt, European Heart Journal	2021	1K
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy George L. Bakris, Rajiv Agarwal, Juliana C.N. Chan, JAMA	2015	673
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress, The Lancet UrologyRenal DiseaseRenal EventsRenal FunctionDiabetes	2019	589
Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial Peter Gæde, Jens Oellgaard, Bendix Carstensen, Diabetologia	2016	505

Page 1